Exact Sciences Corp. today announced that data being presented this afternoon at the annual meeting of the American Association of Clinical Chemistry demonstrates that its methylation specific technology, using a combination of DNA methylation markers, detected 100 percent of colorectal cancers and precancers at a specificity cutoff of 100 percent in a preliminary study with colorectal tissue. Continue Reading
This research service explains the social and economic benefits of healthcare IT implementation in Polish healthcare sector. the study gives an introduction and geographical overview to the healthcare system, its structure and delivery and analyses the key initiatives in the healthcare IT sector. It also analyses the challenges, drivers and restraints of the market in Poland. Continue Reading
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a key patent related to the Company’s proprietary NIMBUS® antimicrobial technology. Continue Reading
Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a key patent related to the Company’s proprietary NIMBUS® antimicrobial technology. Continue Reading
Konica Minolta Sensing Americas, Inc., the worldwide leader in the industrial measurement of color, light and shape, announces its 3D laser scanning open house and medical device workshop July 28, 2010 to be held in its state of the art 3D scanning lab in Ramsey, NJ. Continue Reading
ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, today announced it is offering the Septin 9 methylated DNA test, a new blood-based colorectal cancer screening method. While ARUP is not the first laboratory to offer this test, this new version, developed and validated independently by ARUP, is clinically proven to detect a higher proportion of colorectal cancers than Septin 9 tests developed by other companies. Continue Reading
ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, today announced it is offering the Septin 9 methylated DNA test, a new blood-based colorectal cancer screening method. While ARUP is not the first laboratory to offer this test, this new version, developed and validated independently by ARUP, is clinically proven to detect a higher proportion of colorectal cancers than Septin 9 tests developed by other companies. Continue Reading
Cardiac Science Corporation has issued an update to customers affected by a recall first announced by the Company on November 13, 2009. Continue Reading
Some hospitals are using a “customer management system” to “market to patients and physicians the same way supermarkets do — by sending information they think a customer needs or wants based on their history,” American Medical News reports. “The use of CRM software by the health industry is aided by the increasing automation of data ranging from physician referrals to electronic medical records. Continue Reading
Research conducted by surgeons from the Methodist DeBakey Heart & Vascular Center shows that using robotics reduces blood vessel trauma during minimally invasive procedures to repair diseased arteries. Research results were presented at the Society for Vascular Surgery’s 2010 Vascular Annual Meeting in Boston. Continue Reading
